Q1 2026 earnings call insights: raised guidance, volume outlook, AI ScheduleHub efficiency, and ACA/RPT risks.
In this episode, Javier Rodriguez, CEO of DaVita, shares his perspective on addressing rising chronic conditions, improving access to care, and advancing innovation in kidney treatment. He also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results